ArticleThe Lancet regional health. Europe2025

Cardioprotective glucose-lowering drugs, statins, and risk of first-time atherosclerotic cardiovascular disease in Denmark: a nationwide cohort study.

Tummas Ternhamar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.